This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-FOR-NOW — current cost / risk / redundancy puts it below the line.
Saw Palmetto
Serenoa repens berry extract is marketed as a natural 5α-reductase inhibitor for hair loss and prostate enlargement, but the evidence is brand-dependent and dose-modest.
Aliases (1)
Overview
What is Saw Palmetto?
Serenoa repens berry extract is marketed as a natural 5α-reductase inhibitor for hair loss and prostate enlargement, but the evidence is brand-dependent and dose-modest. Permixon (European hexanic extract, supercritical CO2) has positive RCT evidence for BPH; generic American ethanolic extracts failed the definitive CAMUS 2011 JAMA trial at triple doses. For androgenetic alopecia, modest effect — much smaller than finasteride. For Dylan (20yo, no MPB onset, normal androgen presumption): SKIP. Anti-androgenic load is the wrong directional pressure for a competitive MMA athlete with no prostate/hair indication. Revisit only if MPB emerges and finasteride is specifically rejected for sexual-side-effect concerns.
Peptide Interactions
combined formulas (Prostagutt-Forte, German Rx) show additive BPH benefit. Nettle root binds SHBG and may free up T while saw palmetto reduces DHT, theoretic…
already a major component; supplementing additional β-sitosterol may amplify the 5αR-inhibitor signal modestly (Prager 2002 combo).
anecdotal AGA stack; weak evidence base, but synergistic on a phytosterol basis.
common combo for BPH, weak but consistent evidence.
different mechanism (peripheral vasodilator / hair-cycle modifier). Pairing saw palmetto + minoxidil is the standard "softer" AGA protocol when finasteride i…
anecdotal AGA stack; weak independent evidence; zinc is a mild 5αR inhibitor in vitro.
redundant mechanism; no additive benefit; adds sexual side-effect risk without comparable efficacy gain.
(spironolactone, bicalutamide) — additive feminization risk; only under specific physician-directed protocols (PCOS, prostate cancer, gender-affirming care —…
(warfarin, aspirin >100 mg, clopidogrel) — additive bleeding risk via 5-LOX inhibition. Coordinate with prescriber.
What to Expect
- Week 1Tolerability and dose-response.
- Week 2-4Early effect window.
- Week 4-8Peak benefit assessment.
- Week 8+Cycle decision point.
Side Effects & Safety 8
Side Effects
- 1GI upset / nausea — ~5-10%, especially on empty stomach. Mitigation: take with fatty meal.
- 2Headache — ~3-5%, usually mild and self-limiting.
- 3Dizziness / lightheadedness — uncommon; <2%.
- 4Mild constipation or diarrhea — uncommon.
- 5Sexual side effects: Reduced libido (~1-3%), erectile dysfunction (rare at 320 mg, more common above 600 mg), reduced ejaculate volume (very rare). Generally milder than finasteride. Note: dopamine.club community data shows "sexual-side-effects" as the #1 reported side effect (11 mentions), reflecting selection bias of users dosing higher than 320 mg and/or pre-existing concerns.
- 6Gynecomastia — very rare, case-report level. Mechanism unclear given saw palmetto isn't estrogenic.
- 7Antiplatelet activity — saw palmetto has mild antiplatelet effects (possibly via 5-LOX inhibition). Stop 2 weeks before surgery.
- 8Mild increase in BUN/creatinine — case reports, no consistent pattern.
When to Stop
- Hepatotoxicity — rare clinically apparent hepatic injury (LiverTox classification "rare"). Case reports of cholestatic hepatitis and acute pancreatitis attributed to saw palmetto exist but are sparse. Hepatic events: monitor ALT/AST at baseline and 3-6 months in chronic use; discontinue if jaundice, RUQ pain, or unexplained fatigue + elevated LFTs.
- Acute pancreatitis — case reports; relationship uncertain.
- Bleeding events — case reports of intraoperative bleeding; antiplatelet activity confirmed in vitro.
- First 2 weeks: GI tolerability, any rash or jaundice.
- Weeks 8-12: Subjective libido, sexual function, mood — calibrate against pre-dose baseline.
- Month 3-6: Repeat LFT panel if chronic use, especially with any GI/fatigue symptoms.
References
Bent et al. 2006 — STEP trial: saw palmetto for BPH (NEJM)
definitive negative for generic extract at standard dose.
View StudyBarry et al. 2011 — CAMUS trial: escalating-dose saw palmetto for BPH (JAMA)
definitive negative for ethanolic American extract at 3× dose, 18 months.
View StudyVela-Navarrete et al. 2018 — Permixon hexanic extract meta-analysis (BJU Int)
positive evidence base for Permixon brand specifically.
View StudyNovara et al. 2016 — Permixon meta-analysis
earlier Permixon-only meta confirming hexanic-extract benefit.
View StudyAdisInsight 2022 — Permixon hexanic extract review
extraction methodology dominates extract activity; brands not interchangeable.
View StudyPrager et al. 2002 — saw palmetto + β-sitosterol vs placebo in AGA (J Altern Complement Med)
first formal botanical-5αR-inhibitor AGA evidence.
View StudyEvron et al. 2020 — Saw palmetto in alopecia systematic review (Skin Appendage Disord)
pooled evidence, effect smaller than finasteride.
View StudyAblon et al. 2023 — 16-week RCT oral + topical saw palmetto for AGA (Clin Cosmet Investig Dermatol)
recent positive RCT with combined protocol.
View StudyLatest research
- rctOral and topical standardized saw palmetto oil for androgenetic alopecia — 16-week RCT80 subjects, 400 mg oral + 2-3% β-sitosterol topical for 16 weeks reduced hair fall and improved density vs placebo; effect modest, well-tolerated.
- reviewHexanic extract of Serenoa repens (Permixon) — review in symptomatic BPHConfirms Permixon (hexanic, supercritical CO2) is the only Serenoa preparation with consistent RCT evidence for LUTS/BPH; ethanolic and dry-powder American generics are not equivalent.
- reviewSaw palmetto in alopecia — systematic reviewPooled 5 RCTs + 2 cohorts (n=535). 60% subjective improvement, 27% increase in hair count, modest vs finasteride. Authors note effect size smaller than finasteride; no head-to-head dosing.
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.